Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DR26FDJB2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,472
Award facts
- Contract value 100% obligated
- $10,472.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,472.40 to DMS Pharmaceutical Group Inc. for PRIVIGEN 10% Vial 200ML, effective through November 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order was issued under the company's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense healthcare facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established substantial contracting activity with the Defense Logistics Agency's Medical Supply Chain division, supplying a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support military healthcare operations. The company's single-award Indefinite Delivery Contract under PPV-G GEN V, designated SPE2DR with a $499,999,999 ceiling and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor capable of fulfilling diverse and specialized pharmaceutical requirements across the Department of Defense medical system globally.
Quick answers
Who was awarded contract SPE2DR26FDJB2?
SPE2DR26FDJB2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DR26FDJB2 worth?
The government has obligated $10,472 on SPE2DR26FDJB2.
Is contract SPE2DR26FDJB2 an order under another contract?
Yes. SPE2DR26FDJB2 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJB2 competed?
The extent of competition for SPE2DR26FDJB2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award